Centessa Pharmaceuticals plc - CNTA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G | Pentwater Capital Management LP | 5.3% | 8,170,000 | View |
| May 15, 2026 | SCHEDULE 13G | Matthew Halbower | 5.3% | 8,170,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Avoro Capital Advisors LLC | 7.39% | 11,430,455 | View |
| May 15, 2026 | SCHEDULE 13G/A | Behzad Aghazadeh | 7.39% | 11,430,455 | View |
| May 13, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 5.77% | 8,925,010 | View |
| May 13, 2026 | SCHEDULE 13G/A | Robert Atchinson | 5.77% | 8,925,010 | View |
| May 13, 2026 | SCHEDULE 13G/A | Phillip Gross | 5.77% | 8,925,010 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 7.5% | 6,783,047 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 7.5% | 6,783,047 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Avoro Capital Advisors LLC | 9.97% | 14,555,555 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Behzad Aghazadeh | 9.97% | 14,555,555 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | FMR LLC | 12.2% | 10,999,793 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 12.2% | 10,999,793 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 9.9% | 8,894,939 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 9.9% | 8,894,939 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.